Advertisement
UK markets open in 2 hours 13 minutes
  • NIKKEI 225

    37,185.57
    -894.13 (-2.35%)
     
  • HANG SENG

    16,184.02
    -201.85 (-1.23%)
     
  • CRUDE OIL

    84.49
    +1.76 (+2.13%)
     
  • GOLD FUTURES

    2,400.50
    +2.50 (+0.10%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • Bitcoin GBP

    50,306.43
    +560.54 (+1.13%)
     
  • CMC Crypto 200

    1,284.07
    +398.54 (+43.66%)
     
  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     
  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     

2 Under-the-Radar Biotech Stocks to Buy in 2023

2 Under-the-Radar Biotech Stocks to Buy in 2023

Biotechs that utilize gene editing -- a set of techniques allowing scientists to modify an organism's DNA -- have the potential to help revolutionize medicine by developing innovative treatments for otherwise incurable illnesses. Let's consider two biotechs looking to make use of gene editing to develop breakthrough therapies: CRISPR Therapeutics (NASDAQ: CRSP) and Sarepta Therapeutics (NASDAQ: SRPT).